Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma

by Mantopoulos, Dimosthenis, Kendra, Kari L., Letson, Alan D., Cebulla, Colleen M.
Published in JAMA Ophthalmol (2015)

Refractory dermatitis contributed by pityriasis versicolor: a case report

by Li, Mingjia, Spaccarelli, Natalie, Kendra, Kari, Wu, Richard C., Verschraegen, Claire
Published in J Med Case Rep (2021)

Co-Treatment of Hairy Cell Leukemia and Melanoma with the BRAF Inhibitor Dabrafenib

by Blachly, James S., Lozanski, Gerard, Lucas, David M., Grever, Michael R., Kendra, Kari, Andritsos, Leslie A.
Published in J Natl Compr Canc Netw (2015)

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to Interferon-Alpha

by Zimmerer, Jason M., Lesinski, Gregory B., Ruppert, Amy S., Radmacher, Michael D., Noble, Carl, Kendra, Kari, Walker, Michael J., Carson, William E.
Published 2008

A Pilot Study of Bevacizumab and Interferon-α2b in Ocular Melanoma

by Guenterberg, Kristan D., Grignol, Valerie P., Relekar, Kiran V., Varker, Kimberly A., Chen, Helen X., Kendra, Kari L., Olencki, Thomas E., Carson, William E.
Published in Am J Clin Oncol (2011)

Hybrid Capture‐Based Genomic Profiling Identifies BRAF V600 and Non‐V600 Alterations in Melanoma Samples Negative by Prior Testing

by Boussemart, Lise, Nelson, Annie, Wong, Michael, Ross, Jeffrey S., Sosman, Jeffrey, Mehnert, Janice, Daniels, Gregory, Kendra, Kari, Ali, Siraj Mahamed, Miller, Vincent A., Schrock, Alexa B.
Published in Oncologist (2019)

Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study

by Galloway, Jason E., Holderbaum, Andrea M., Arya, Namrata, Zhang, Suohui, Bodnar, Michael S., Norman, Ruthann, Carson, William E., Yu, Lianbo, Kendra, Kari L., Burd, Christin E.
Published in Aging Cancer (2020)

A Phase II trial of Bevacizumab and High Dose Interferon Alpha-2B in Metastatic Melanoma

by Grignol, Valerie P., Olencki, Thomas, Relekar, Kiran, Taylor, Cynthia, Kibler, Amanda, Kefauver, Cheryl, Wei, Lai, Walker, Michael J., Chen, Helen X., Kendra, Kari, Carson, William E.
Published 2011

Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib

by Liebner, David A., Walston, Steven A., Cavaliere, Robert, Powers, Ciaran J., Sauvageau, Eric, Lehman, Norman L., Slone, Hasel Wayne, Xu-Welliver, Meng, Xia, Fen, Kendra, Kari L.
Published in Melanoma Res (2014)

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

by Monk, Paul, Lam, Elaine, Mortazavi, Amir, Kendra, Kari, Lesinski, Gregory B., Mace, Thomas A., Geyer, Susan, Carson, William E., Tahiri, Sanaa, Bhinder, Arvinder, Clinton, Steven K., Olencki, Thomas
Published 2014

Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells

by Yang, Jennifer, Bill, Matthew A., Young, Gregory S., La Perle, Krista, Landesman, Yosef, Shacham, Sharon, Kauffman, Michael, Senapedis, William, Kashyap, Trinayan, Saint-Martin, Jean-Richard, Kendra, Kari, Lesinski, Gregory B.
Published 2014

The exportin-1 inhibitor selinexor exerts superior anti-tumor activity when combined with T cell checkpoint inhibitors

by Farren, Matthew R., Hennessey, Rebecca C., Shakya, Reena, Elnaggar, Omar, Young, Gregory, Kendra, Kari, Landesman, Yosef, Elloul, Sivan, Crochiere, Marsha, Klebanov, Boris, Kashyap, Trinayan, Burd, Christin E., Lesinski, Gregory B.
Published in Mol Cancer Ther (2017)

Development and Validation of Sensitive Liquid Chromatography/Tandem Mass Spectrometry Methods for Quantification of Bendamustine in Mouse Brain Tissue

by He, Lei, Grecula, John C., Ling, Yonghua, Enzerra, Michael D., Ammirati, Mario, Kendra, Kari, Cavaliere, Robert, Mayr, Nina, McGregor, John, Olencki, Thomas, Mrozek, Ewa, Matharbootham, Mani, Oluigbo, Chima, Phelps, Mitch A.
Published 2012

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

by Hasanov, Merve, Rioth, Matthew J., Kendra, Kari, Hernandez-Aya, Leonel, Joseph, Richard W., Williamson, Stephen, Chandra, Sunandana, Shirai, Keisuke, Turner, Christopher D., Lewis, Karl, Crowley, Elizabeth, Moscow, Jeffrey, Carter, Brett, Patel, Sapna
Published in Cancers (Basel) (2020)

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

by Li, Mingjia, Spakowicz, Daniel, Burkart, Jarred, Patel, Sandip, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Carbone, David P., Verschraegen, Claire F., Presley, Carolyn J., Otterson, Gregory A., Kendra, Kari, Owen, Dwight H.
Published in J Cancer Res Clin Oncol (2019)

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

by King, David M., Albertini, Mark R., Schalch, Heidi, Hank, Jacquelyn A., Gan, Jacek, Surfus, Jean, Mahvi, David, Schiller, Joan H., Warner, Thomas, Kim, KyungMann, Eickhoff, Jens, Kendra, Kari, Reisfeld, Ralph, Gillies, Stephen D., Sondel, Paul
Published 2004

A Phase I trial of Bortezomib and Interferon Alfa-2B in Metastatic Melanoma

by Markowitz, Joseph, Luedke, Eric A., Grignol, Valerie P., Hade, Erinn M., Paul, Bonnie K., Mundy-Bosse, Bethany L., Brooks, Taylor R., Dao, Thao-Vi, Kondalasula, Sri Vidya, Lesinski, Gregory B., Olencki, Thomas, Kendra, Kari L., Carson, William E.
Published 2014

A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

by Suarez-Kelly, Lorena P., Levine, Kala M., Olencki, Thomas E., del Campo, Sara E. Martin, Streacker, Elizabeth A., Brooks, Taylor R., Karpa, Volodymyr I., Markowitz, Joseph, Bingman, Anissa K., Geyer, Susan M., Kendra, Kari L., Carson, William E.
Published in Cancer Immunol Immunother (2019)

Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma

by Galanis, Evanthia, Markovic, Svetomir N, Suman, Vera J, Nuovo, Gerard J, Vile, Richard G, Kottke, Timothy J, Nevala, Wendy K, Thompson, Michael A, Lewis, Jean E, Rumilla, Kandelaria M, Roulstone, Victoria, Harrington, Kevin, Linette, Gerald P, Maples, William J, Coffey, Matt, Zwiebel, James, Kendra, Kari
Published 2012

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

by Abu-Sbeih, Hamzah, Ali, Faisal S., Naqash, Abdul Rafeh, Owen, Dwight H., Patel, Sandipkumar, Otterson, Gregory A., Kendra, Kari, Ricciuti, Biagio, Chiari, Rita, De Giglio, Andrea, Sleiman, Joseph, Funchain, Pauline, Wills, Beatriz, Zhang, Jiajia, Naidoo, Jarushka, Philpott, Jessica, Gao, Jianjun, Subudhi, Sumit K., Wang, Yinghong
Published in J Clin Oncol (2019)